These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 5807303)

  • 21. Abnormal glucose tolerance in beta-thalassemia: assessment of risk factors.
    Hafez M; Youssry I; El-Hamed FA; Ibrahim A
    Hemoglobin; 2009; 33(2):101-8. PubMed ID: 19373585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of fetal hyperinsulinism on oral glucose tolerance test results in patients with gestational diabetes mellitus.
    Weiss PA; Scholz HS; Haas J; Tamussino KF
    Am J Obstet Gynecol; 2001 Feb; 184(3):470-5. PubMed ID: 11228505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired glucose metabolism in colorectal cancer.
    Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
    Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blood glucose abd hormonal counterregulation in juvenile type I diabetics during exercise (author's transl)].
    Borkenstein J; Borkenstein M
    Acta Med Austriaca; 1981; 8(3):82-4. PubMed ID: 7023167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
    Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
    Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Juvenile diabetes with long-term remission].
    Hayakawa H; Takamatsu H; Kubo T; Sanada I; Takazakura E
    Naika; 1970 Feb; 25(2):378-82. PubMed ID: 5438423
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum insulin in remission of juvenile diabetes.
    Hernandez A; Zorrilla E; Gershberg H
    Lancet; 1968 Jul; 2(7561):223. PubMed ID: 4173442
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma-insulin in mild juvenile diabetes.
    Johansen K; Lundbaek K
    Lancet; 1967 Jun; 1(7502):1257-9. PubMed ID: 4165043
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunoregulation in juvenile diabetes].
    Moncada E; Subirá ML; Barbería JJ; Salvador J; Sánchez Ibarrola A; Cano I; Goñi F; Oleaga A
    Rev Clin Esp; 1988 Jun; 183(2):61-6. PubMed ID: 3175165
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum-insulin levels in children during glucose tolerance tests.
    Grant DB
    Acta Paediatr Scand; 1968 Jul; 57(4):297-9. PubMed ID: 5706046
    [No Abstract]   [Full Text] [Related]  

  • 33. JUVENILE DIABETES: EARLY OBSERVATIONS OF 181 CASES.
    RIPPY EL
    Tex State J Med; 1964 Mar; 60():226-31. PubMed ID: 14131724
    [No Abstract]   [Full Text] [Related]  

  • 34. JUVENILE DIABETES.
    WHITE P
    J Lancet; 1963 Sep; 83():358-64. PubMed ID: 14047800
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemical diabetes in the juvenile patient.
    Colle E; Belmonte MM
    Metabolism; 1973 Feb; 22(2):345-9. PubMed ID: 4687959
    [No Abstract]   [Full Text] [Related]  

  • 36. An abnormal insulin in juvenile diabetes mellitus.
    Elliott RB; O'Brien D; Roy CC
    Diabetes; 1965 Dec; 14(12):780-7. PubMed ID: 5892262
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum-insulin in remission of juvenile diabetes.
    Orskov H; Johansen K
    Lancet; 1968 Nov; 2(7577):1081. PubMed ID: 4176888
    [No Abstract]   [Full Text] [Related]  

  • 38. Impaired leukotactic responsiveness in patients with juvenile diabetes mellitus.
    Hill HR; Sauls HS; Dettloff JL; Quie PG
    Clin Immunol Immunopathol; 1974 Apr; 2(3):395-403. PubMed ID: 4826528
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum-insulin or plasma-insulin?
    Henderson JR
    Lancet; 1971 Dec; 2(7739):1430-1. PubMed ID: 4107618
    [No Abstract]   [Full Text] [Related]  

  • 40. Juvenile diabetes.
    Indian Pediatr; 1968 Oct; 5(10):479-80. PubMed ID: 5716990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.